02
Dec
India ranks third globally in HIV cases, with 24.01 lakh patients. In 2021, India had 63,000 new cases and 50,000 AIDS-related deaths. HIV remains a significant challenge for detection and treatment. Newer treatment options, such as Integrase strand transfer inhibitors (INSTIs), have shown promising results in HIV management. These drugs reduce HIV virus levels, ensuring better management. Dolutegravir, a new INSTI drug, suppresses and limits virus multiplication Dr Soumyadip Chatterji, a renowned Infectious Diseases Specialist, highlighted the advantages of Dolutegravir, a new-generation Integrase strand transfer inhibitor (INSTI) in the HIV drugs arsenal. INSTIs prevent the HIV virus from incorporating into…
